Concepedia

Ha Dong Kim

HD

4

Publications

145

Citations

4

H-Index

2011

Active since

Affiliations

Dong-A Pharmaceutical (South Korea)(Current)

Seoul National University

Ha Dong Kim is an author at Dong-A Pharmaceutical (South Korea) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2011–2017

4

Publications

4

DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes

Mi Kyung Kim, Yu Na Chae, Ha Dong Kim et al. · Life Sciences · 2011 · 62 citations

, , +11

Discovery of DA-1229: A potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

Heung Jae Kim, Woo Young Kwak, Jong Pil Min et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 52 citations · Full text

, , +7

Unique binding mode of Evogliptin with human dipeptidyl peptidase IV

Hyung Ki Lee, Mi‐Kyung Kim, Ha Dong Kim et al. · Biochemical and Biophysical Research Communications · 2017 · 19 citations

, , +4

Dipeptidyl peptidase-4 inhibitor with β-amino amide scaffold: Synthesis, SAR and biological evaluation

Heung Jae Kim, Woo Young Kwak, Jong Pil Min et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 12 citations · Full text

, , +12

Rows per page

1–4 of 4